EUVIMEDEUVIMED entdecken
Crossref

Weight Variations during First-Line Systemic Treatment of Metastatic Non-Small Cell Lung Cancer: New Paradigms from Real-World Data

Alexandre Gravian, Arnaud Pagès, Anthony Tarabay, Virginie Delaye, Florian Scottée, Mansouria Merad, Sami Antoun

Oncology · 02.03.2026 · 104 (8) · 891-899

DOI: 10.1159/000550347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology, online erschienen am 02.03.2026. Verfasst von Alexandre Gravian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service de Médecine Aigüe en Cancérologie, Gustave Roussy, Villejuif, France, alexandre.gravian@gustaveroussy.fr. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Weight Loss, Immune Checkpoint Inhibitors. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In studies, weight loss is strongly associated with outcomes in metastatic non-squamous cell lung cancer (mNSCLC). This work examines weight variations in first-line treatment, exploring their mechanisms based on treatment type, age, sex, weight loss, and excess weight before treatment.

Methods

A retrospective analysis was conducted on patients undergoing first-line treatment. Weight was recorded at four points: before treatment (Wbe), day 1 of treatment (Wd1), 3 months into immune checkpoint inhibitors (ICIs) treatment or maintenance (W3mo), and at progression diagnosis (Wpro).

Results

Among patients (n = 198), 47% received chemotherapy (CT) with ICIs, 26% CT alone, and 27% ICIs alone. At Wd1, 32% were overweight/obese (body mass index kg/m2) (BMI ≥ 25). Weight loss ≥ 5% before treatment was observed in 37%. Mean (SD) weight variations between Wd1 and W3mo were −1.1% (4.6) (CT), −0.2% (7.1) (CT+ICIs), and +0.4% (7.7) (ICIs alone) (p = 0.52). Patients older than 70 compared to ≤70 lost more weight between Wd1 and Wpro (−4.7% vs. −0.4%) (p = 0.019). Patients with pre-treatment weight loss ≥ 5% compared to those without weight loss stabilized or gained weight during treatment (+2.1% vs. −1.5%) (p = 0.009). Patients with BMI ≥ 25 lost more weight during treatment than those with BMI

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsWeight LossImmune Checkpoint InhibitorsAntineoplastic Combined Chemotherapy ProtocolsBody WeightHumansFemaleRetrospective StudiesMaleAgedMiddle AgedBody Mass IndexAged, 80 and overObesityNeoplasm Metastasis

Stichwörter der Autor:innen

First-line treatmentImmune check point inhibitorNon-small cell lung cancerOlder patientsOverweightWeight loss

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Service de Médecine Aigüe en Cancérologie, Gustave Roussy, Villejuif, France, alexandre.gravian@gustaveroussy.fr.
  • Bureau de Biostatistique et d'Epidémiologie, Gustave Roussy, et CESP U1018, Oncostat, Labellisé Ligue Contre le Cancer, Inserm, Villejuif, France.
  • Service de Médecine Aigüe en Cancérologie, Gustave Roussy, Villejuif, France.
  • Département Interdisciplinaire d'Organisation du Parcours Patient (DIOPP), Gustave Roussy, Villejuif, France.

Zitieren

APA

Gravian, A., Pagès, A., Tarabay, A., Delaye, V., Scottée, F., Merad, M., & Antoun, S. (2026). Weight Variations during First-Line Systemic Treatment of Metastatic Non-Small Cell Lung Cancer: New Paradigms from Real-World Data. Oncology, 104(8), 891-899. https://doi.org/10.1159/000550347

Vancouver

Gravian A, Pagès A, Tarabay A, Delaye V, Scottée F, Merad M, et al. Weight Variations during First-Line Systemic Treatment of Metastatic Non-Small Cell Lung Cancer: New Paradigms from Real-World Data. Oncology. 2026;104(8):891-899. doi:10.1159/000550347

BibTeX
@article{Gravian2026,
  author = {Gravian, Alexandre and Pagès, Arnaud and Tarabay, Anthony and Delaye, Virginie and Scottée, Florian and Merad, Mansouria and Antoun, Sami},
  title = {Weight Variations during First-Line Systemic Treatment of Metastatic Non-Small Cell Lung Cancer: New Paradigms from Real-World Data},
  journal = {Oncology},
  year = {2026},
  volume = {104},
  number = {8},
  pages = {891--899},
  doi = {10.1159/000550347}
}
Kostenlos starten →